Ragnarson Tennvall G, Hjortsberg C, Bjarnason A, Gniadecki R, Heikkilä H, Jemec GB, Kragballe K, Miller IM & Svensson A
Treatment Patterns, Treatment Satisfaction, Severity of Disease Problems, and Quality of Life in Patients with Psoriasis in Three Nordic Countries
Acta Derm Venereol. 2012 Nov 9 [Epub ahead of print]

Anell A, Glenngård AH & Merkur S
Sweden health system review
Health Syst Transit. 2012; 14(5): 1-159

Glenngård AH, Hjelmgren J, Thomsen PH & Tvedten T
Patient preferences and willingness-to-pay for ADHD treatment with stimulants using discrete choice experiment (DCE) in Sweden, Denmark and Norway
Nord J Psychiatry. 2012 Dec 17. [Epub ahead of print]

Glenngård A H
Is patient satisfaction in primary care dependent on structural and organizational characteristics among providers? Findings based on data from the national patient survey in Sweden
Health Economics, Policy and Law. 2012, FirstView Article, pp 1-16

Asseburg C, Willis M, Löthgren M, Seppälä N, Hakala M & Persson U
Hospitalisation Utilisation and Costs in Schizophrenia Patients in Finland before and after Initiation of Risperidone Long-Acting Injection
Schizophrenia Research and Treatment. 2012; Volume 2012, Article ID 791468, 9 pages

Svensson J, Lundberg J, Olsson P, Stjärne P & Tennvall GR
Cost-effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis
Prim Care Respir J. 2012; 21(4): 412-8

Borg S, Näslund I, Persson U & Ödegaard K
Budget impact analysis of surgical treatment for obesity in Sweden
Scandinavian Journal of Surgery 2012; 101(3): 190–197

Lökk J, Persson U & Wainwright M
Social and Economic Benefits of Early Optimised Treatment for Parkinson´s Disease Patients - Improved Quality of Life and Greater Productivity
European Neurological Review 2012; 7(2): 113-117
Foreword by Susanna Lindvall


Hjalte F, Brännström J & Gerdtham U G
Societal costs of hearing disorders: A systematic and critical review of literature
International Journal of Audiology, 2012; 51(9): 655-662

Lindvall K, Astermark J, Björkman S, Ljung R, Steen Carlsson K, Persson S and Berntorp E
Daily dosing prophylaxis for haemophilia: a randomized crossover pilot study evaluating feasibility and efficacy
Haemophilia, 2012, first published online 11 June

Persson U, Svensson J & Pettersson B.
A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing.
Applied Health Economics and Health Policy, 2012; 10(4): 217-25

Lökk J, Borg S, Svensson J, Persson U & Ljunggren G
Drug and treatment costs in Parkinson´s disease patients in Sweden
Acta Neurologica Scandinavica 2012 Feb; 125(2): 142-7

Svensson J, Ghatnekar O, Lindgren A, Lindvall O, Norrving B, Persson U & Kokaia Z.
Societal Value of Stem Cell Therapy in Stroke - A Modeling Study.
Cerebrovascular Diseases, 2012; 33(6): 532-539

Thorsén F, Rosberg H-E, Steen Carlsson K & Dahlin L B
Digital nerve injuries: Epidemiology, results, costs, and impact on daily life

Journal of Plastic Surgery and Hand Surgery, 2012; Early Online: 1–7

Ghatnekar O, Ljungberg A, Wirestrand L E, Svensson A
Costs and quality of life for psoriatic patients at different degrees of severity in southern Sweden - a cross-sectional study.

European Journal of Dermatology. 2012 Mar-Apr;22(2):238-45

Norlin J.M., Steen Carlsson K., Persson U., Schmitt-Egenolf M.
Analysis of three outcome measures in moderate to severe psoriasis: a registry-based study of 2450 patients
Britsh Journal of Dermatology, Vol 166, Issue 4, pages 797-802